SB 505124
Tocris Bioscience, part of Bio-Techne | Catalog # 3263
Selective inhibitor of TGF-βRI, ALK4 and ALK7
Key Product Details
Description
Selective inhibitor of TGF-βRI, ALK4 and ALK7
Product Description
SB 505124 is a selective inhibitor of transforming growth factor-β type I receptor (ALK5), ALK4 and ALK7 (IC50 values are 47 and 129 nM for ALK5 and ALK4 respectively). Selectively inhibits signaling from TGF-β and activin; does not inhibit other ALK family members. Promotes adenine base editor activity in vivo and in vitro at 10 μM.Product Specifications
Molecular Weight
335.40
Formula
C20H21N3O2
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
2-[4-(1,3-Benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-5-yl]-6-methyl-pyridine
CAS Number
694433-59-5
PubChem ID
9858940
InChI Key
WGZOTBUYUFBEPZ-UHFFFAOYSA-N
SMILES
CC(C)(C)C1=NC(C2=CC(OCO4)=C4C=C2)=C(C3=NC(C)=CC=C3)N1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 33.54 | 100 | |
| 2eq. HCl | 33.54 | 100 |
Preparing Stock Solutions
for SB 505124
The following data is based on the product molecular weight 335.40
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.98 mL | 14.91 mL | 29.82 mL |
| 5 mM | 0.60 mL | 2.98 mL | 5.96 mL |
| 10 mM | 0.30 mL | 1.49 mL | 2.98 mL |
| 50 mM | 0.06 mL | 0.30 mL | 0.60 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Yang Small-molecule activators specific to adenine base editors through blocking the canonical TGF-β pathway. Nucleic Acids Res. 2022 PMID: 36043443
- Hu Reactive oxygen species production via NADPH oxidase mediates TGF-β-induced cytoskeletal alterations in endothelial cells. Am.J.Physiol.Renal Physiol. 2005 PMID: 16159901
- Noma The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. Gastroenterology 2008 PMID: 18439605
- Byfield SB-505124 is a selective inhibitor of transforming growth factor-β type I receptors ALK4, ALK5, and ALK7. Mol.Pharmacol. 2004 PMID: 14978253
Product Specific Notices for SB 505124
For research use only
Loading...
Loading...